US Pharma MarketingASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger
Eli Lilly arrived at the American Society of Clinical Oncology meeting in Chicago this morning armed with early data for a new drug that could, if all goes right, challenge the dominance of Pfizer Eli Lilly took to the stage at the American Society of Clinical Oncology meeting in Chicago to share early data for a new drug candidate that could, if all goes right, challenge the dominance of Pfizer and Astellas Pharma’s Padcev in bladder cancer. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending…
Eli Lilly took to the stage at the American Society of Clinical Oncology meeting in Chicago to share early data for a new drug candidate that could, if all goes right, challenge the dominance of Pfizer and Astellas Pharma’s Padcev in bladder cancer.
Source: FierceBiotech